Oncolytic Virus Therapy Market to Witness Huge Growth by 2025 | Key Players: Lokon Pharma , Merck , MultiVir , Oncolys BioPharma

Oncolytic Virus Therapy Market

The study covers key regions that includes North America, Europe,  Asia-Pacific, South America  and important players such as Lokon Pharma  , Merck  , MultiVir  , Oncolys BioPharma etc

Request a sample report @ https://www.htfmarketreport.com/sample-report/1489766-global-oncolytic-virus-therapy-market-5

Scope of the Study
An oncolytic virus is a virus that favorably infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune responses. A number of viruses including adenovirus, reovirus, measles, herpes simplex, Newcastle disease virus and vaccinia have now been clinically tested by oncolytic therapy and found good results. The increasing global prevalence of chronic diseases and lifestyle disorders is one of the major factors propelling this market. These diseases majorly include cardiovascular diseases, cancer, stroke, infectious diseases, lung disorders, diabetes, chronic kidney diseases, and liver diseases. There are almost 48 oncolytic virus therapy are available in the market.. The market study is being classified by Type (Onxy-15 , RIGVIR , Talimogene laherparepvec (T-VEC) and Reolysin), by Application (Lung Cancer , Prostate Cancer , Melanoma , Brain Tumor and Others) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America) , Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific) , Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe) , MEA (Middle East, Africa) , North America (United States, Canada, Mexico) .

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=1489766

Crusade Laboratories (United Kingdom) , Genelux Corporation (United States) , Oncolytics Biotech (Canada) , Oncos Therapeutics (Finland) , Jennerex Biotherapeutics (United States) , Lokon Pharma (Sweden) , Merck (United States) , MultiVir (United States) , Oncolys BioPharma (Japan) , BioVex (United States) , Cell Genesys (United States) , PsiOxus Therapeutics (United Kingdom) and Shanghai Sunway Bioteh (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Takara Bio (Japan) , VCN Biosciences (Spain) , ViroTarg (Australia) and Vyriad (United States).

Market Drivers
Increasing number of cancer patients
Increasing awareness regarding very less toxic effect as compared to other conventional and chemotherapy

Market Trend
48 oncolytic virus therapy are available in the market
Imlygic is an advanced therapy widely used

Restraints
Knowledge of serious side effects of therapy
High cost

Opportunities
Increase in global warming and Huge investment in research and development by key vendors

Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/1489766-global-oncolytic-virus-therapy-market-5

Table of Contents

1 Market Overview

    1.1  Oncolytic Virus Therapy Introduction

    1.2 Market Analysis by Type

    1.3 Market Analysis by Applications

    1.4 Market Analysis by Regions

        1.4.1 North America (United States, Canada and Mexico)

            1.4.1.1 United States Market States and Outlook (2013-2023)

            1.4.1.2 Canada Market States and Outlook (2013-2023)

            1.4.1.3 Mexico Market States and Outlook (2013-2023)

        1.4.2 Europe (Germany, France, UK, Russia and Italy)

            1.4.2.1 Germany Market States and Outlook (2013-2023)

            1.4.2.2 France Market States and Outlook (2013-2023)

            1.4.2.3 UK Market States and Outlook (2013-2023)

            1.4.2.4 Russia Market States and Outlook (2013-2023)

            1.4.2.5 Italy Market States and Outlook (2013-2023)

        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

            1.4.3.1 China Market States and Outlook (2013-2023)

            1.4.3.2 Japan Market States and Outlook (2013-2023)

            1.4.3.3 Korea Market States and Outlook (2013-2023)

            1.4.3.4 India Market States and Outlook (2013-2023)

            1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

        1.4.4 South America, Middle East and Africa

            1.4.4.1 Brazil Market States and Outlook (2013-2023)

            1.4.4.2 Egypt Market States and Outlook (2013-2023)

            1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

            1.4.4.4 South Africa Market States and Outlook (2013-2023)

            1.4.4.5 Nigeria Market States and Outlook (2013-2023)

    1.5 Market Dynamics

        1.5.1 Market Opportunities

        1.5.2 Market Risk

        1.5.3 Market Driving Force

2 Manufacturers Profiles

        2.1.1 Business Overview

        2.1.2  Oncolytic Virus Therapy Type and Applications

        2.1.3  Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global  Oncolytic Virus Therapy Market Competition, by Manufacturer

    3.1 Global  Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)

    3.2 Global  Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)

    3.3 Global  Oncolytic Virus Therapy Price by Manufacturer (2016-2017)

    3.4 Market Concentration Rate

        3.4.1 Top 3  Oncolytic Virus Therapy Manufacturer Market Share in 2017

        3.4.2 Top 5  Oncolytic Virus Therapy Manufacturer Market Share in 2017

    3.5 Market Competition Trend

….Continued

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Media Contact
Company Name: HTF Market Intelligence Consulting Private Limited
Contact Person: Craig Francis
Email: Send Email
Phone: 2063171218
Address:Unit No. 429, Parsonage Road
City: Edison
State: New Jersey
Country: United States
Website: www.htfmarketreport.com/reports/1489766-global-oncolytic-virus-therapy-market-5